Cancer Nanotechnology

OCT 23, 2026 · JOURNAL ARTICLE

Lipid nanoparticle platforms for p53-targeted cancer therapy

Cancer Nanotechnology

Lipid nanoparticles (LNPs) have emerged as the most clinically validated nanocarrier platform in oncology, transitioning from liposomal chemotherapy to the cornerstone of mRNA-base

OCT 20, 2026 · JOURNAL ARTICLE

Targeted delivery of boron depots containing immune adjuvant to achieve efficient cancer therapy via a combination of BNCT and cancer vaccine

Cancer Nanotechnology

Despite the recent progress in cancer treatment, the 5-year survival rates for many types of cancer are still below 30%. The current therapeutic modalities are subject to significa

OCT 15, 2026 · JOURNAL ARTICLE

Efficient delivery of DMDD by an iron-engineered mesoporous organosilica nanoplatform reshapes the breast cancer immune microenvironment via autophagy activation and immune checkpoint modulation

Cancer Nanotechnology

Breast cancer is the most common malignancy worldwide. Patients with advanced disease often experience recurrence and metastasis, driven by the immunosuppressive tumor microenviron

OCT 12, 2026 · JOURNAL ARTICLE

Stem cell-derived extracellular vesicles in cancer theranostics: dual regulatory mechanisms, engineering strategies, and clinical translation

Cancer Nanotechnology

Stem cells, known for their exceptional self-renewal and multilineage differentiation capabilities, play critical roles in tumor initiation, progression, and therapeutic strategies

SEP 28, 2026 · JOURNAL ARTICLE

Self-assembled products from natural active compounds: mechanisms and applications in cancer therapy

Cancer Nanotechnology

Natural active compounds (NACs) possess diverse anticancer activities but are often limited by poor aqueous solubility, low bioavailability, insufficient tumor selectivity, and ina

SEP 27, 2026 · JOURNAL ARTICLE

GE11-engineered small extracellular vesicles enable targeted delivery of miR-204 in EGFR1-positive triple-negative breast cancer cells

Cancer Nanotechnology

Triple-negative breast cancer (TNBC) remains one of the most aggressive breast cancer subtypes, with high metastatic potential, frequent recurrence, and limited treatment options d

AUG 17, 2026 · JOURNAL ARTICLE

Piezoelectric nanozymes: a new frontier for next-generation tumor therapeutics

Cancer Nanotechnology

This is a narrative review of piezoelectric nanozyme mechanisms and design strategies in preclinical cancer models, raising conceptual and mechanistic questions rather than reporting clinical outcomes or rigorous comparative efficacy data.